natgillin/translations-raw huggingface dataset:
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Ravicti, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Ravicti omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Rebif, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Rebifi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Relistor, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Relistori omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Relvar Ellipta, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Remsima, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Remsima ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavate ettevaatusmeetmete teave.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Repatha, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Repatha omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Revinty Ellipta, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Revlimid, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Revlimidi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Revolade, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Revolade omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Ruconest, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Ruconesti omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Senshio, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Senshio omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sevelamer carbonate Zentiva, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Sevelamer carbonate Zentiva omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Signifor, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Signifori omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Silgard, including the appropriate precautions to be followed by healthcare professionals and patients.
Kava alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Silgardi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Soliris, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Solirise omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for SonoVue, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati SonoVue omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sovaldi, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Sovaldi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sprycel, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Spryceli omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Stayveer, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Stayveeri ohutusteave koos vastavate ettevaatusabinõudega tervishoiuspetsialistidele ja patsientidele.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Stivarga, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Stivarga ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Strensiq, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Strensiqi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Stribild, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Stribildi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavate ettevaatusmeetmete teave.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sustiva, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Sustiva omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Sylvant, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Sylvanti omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Synflorix, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Synflorixi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Synjardy, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Synjardy omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tafinlar, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tafinlari omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tagrisso, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tagrisso omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tamiflu, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tamiflu omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tarceva, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tarceva omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Thalidomide Celgene, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Thalidomide Celgene omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Thymanax, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Thymanaxi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tivicay, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Tivicay ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Toujeo, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Toujeo omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tracleer, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tracleeri omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Translarna, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Translarna omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Tyverb, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Tyverbi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Uptravi, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Uptravi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Valdoxan, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Valdoxani ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Vectibix, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Vectibixi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Viekirax, including information on the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Viekiraxi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Viread, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Vireadi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Vitekta, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Vitekta omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Volibris, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Volibrise omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Voncento, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Voncento omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Voriconazole Hospira, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Voriconazole Hospira omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Votubia, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Votubia omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xeloda, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Xeloda omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xgeva, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Xgeva omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xigduo, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Xigduo ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad ettevaatusmeetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xofigo, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati ravimi omaduste kokkuvõttesse ja pakendi infolehele Xofigo ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xtandi, including the appropriate precautions to be followed by healthcare professionals and patients.
Strateegiast lähtudes lisati Xtandi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad ettevaatusmeetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Xultophy, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Xultophy omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Yervoy, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Yervoy omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Zerbaxa, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Zerbaxa omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Zoledronic Acid Accord, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Zoledronic Acid Accordi omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this plan, the safety information has been included in the summary of product characteristics and the package leaflet for Daxas, including the appropriate precautions to be followed by healthcare professionals and patients.
Selle alusel lisati Daxase omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
Based on this prescribed dose, calculate the total dose to be given.
Soovitatava annuse alusel tuleb arvutada manustatav üldannus.
Based on this trial and population pharmacokinetic analysis of data derived from clinical trials in various tumour types, it is concluded, that adjustments to the starting dose in patients with mild (eGFR 60-89 mL/min/1.73m²), moderate (eGFR 30-59 mL/min/1.73m²), or severe (eGFR 15-29 mL/min/1.73m²) renal impairment are not necessary, but patients with severe impairment should be monitored (see “Population pharmacokinetic analysis in special populations” below and section 4.2).
Selle uuringu ja mitmesuguste kasvajatüüpidega patsientidega tehtud kliinilistest uuringutest saadud andmete populatsiooni farmakokineetilise analüüsi tulemuste alusel järeldati, et algannuse kohandamine ei ole kerge (eGFR 60...89 ml/min/1,73 m2), mõõduka (eGFR 30...59 ml/min/1,73 m2) ega raske (eGFR 15...29 ml/min/1,73 m2) neerufunktsiooni kahjustusega patsientidel vajalik, kuid raske neerufunktsiooni kahjustusega patsiente peab jälgima (vt alljärgnevat lõiku „Populatsiooni farmakokineetiline analüüs eripopulatsioonides‟ ja lõiku 4.2).
Based on tolerability and efficacy, the dose may be increased to Vivanza 10 mg and 20 mg film-coated tablets, or Vivanza 10 mg orodispersible tablets.
Sõltuvalt efektiivsusest ja taluvusest võib annust suurendada Vivanza 10 mg või 20 mg õhukese polümeerikattega tablettide, või Vivanza 10 mg suus dispergeeruvate tablettideni.